NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Ritchies posts $17m annual net loss
Markets

Ritchies posts $17m annual net loss

The bus operator's net loss widened from $8m to $17m in the year to March 31.

John Anthony 30 Aug 2024
Penno v analysts: what is Synlait worth?
Primary Sector

Penno v analysts: what is Synlait worth?

The Synlait founder says Fonterra is performing really well.

Peter Jackson pays $40m above RV for potential museum site
Property

Peter Jackson pays $40m above RV for potential museum site

It looks like Jackson has ‘something special’ planned, councillor Tim Brown says.

Gregor Thompson 28 Aug 2024
At Large rises out of SenateSHJ collapse
Economy

At Large rises out of SenateSHJ collapse

A new public relations firm has risen out of the ashes of SenateSHJ’s Wellington office.

Dileepa Fonseka 28 Aug 2024